Evidence map›Paper›PMID 21865655›Full record

ArticleDevelopmental neuroscience2011

Strain-specific differences in perinatal rodent oligodendrocyte lineage progression and its correlation with human.

Justin M Dean, Matthew D Moravec, Marjorie Grafe, Nicholas Abend, Jennifer Ren, Xi Gong, Joseph J Volpe, Frances E Jensen, A Roger Hohimer, Stephen A Back

Open access · greenAbstract read
In one paragraph

Article in Developmental neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 51 papers.

0numbers the graph read from it
0cells of the map it votes in
51citing papers in PubMed
9.6field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

51 citing papers in PubMed, 92 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Review
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Justin M DeanDepartment of Pediatrics, Oregon Health and Science University, Portland, OR 97239-3098, USA.
Matthew D Moravec
Marjorie Grafe
Nicholas Abend
Jennifer Ren
Xi Gong
Joseph J Volpe
Frances E Jensen
A Roger Hohimer
Stephen A Back
Oregon Health & Science University · USHarvard University Press · US

Funding

SYNAPTIC MECHANISMS IN HIPPOCAMPAL EPILEPTOGENESISP30HD018655 · NICHD · CHILDREN'S HOSPITAL BOSTON · PI CHEN, CHINFEI · 1985 to 2015
$26.2M
PERIVENTRICULAR LEUKOMALACIA IN THE PREMATURE INFANTP01NS038475 · NINDS · CHILDREN'S HOSPITAL BOSTON · PI VOLPE, JOSEPH J · 2000 to 2009
$13.2M
Role of Extracellular Matrix in Hypoxic-Ischemic Perinatal White Matter InjuryR01NS054044 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI BACK, STEPHEN ARTHUR · 2006 to 2021
$4.8M
Understanding the Cognitive Impact of Early Life EpilepsyDP1OD003347 · OD · UNIVERSITY OF PENNSYLVANIA · PI JENSEN, FRANCES E · 2007 to 2011
$4.2M
The Epileptogenic Effect of Perinatal HypoxiaR01NS031718 · NINDS · CHILDREN'S HOSPITAL BOSTON · PI JENSEN, FRANCES E · 1997 to 2011
$3.8M
Cellular mechanisms of fetal white matter injuryR37NS045737 · NINDS · OREGON HEALTH & SCIENCE UNIVERSITY · PI BACK, STEPHEN ARTHUR · 2007 to 2013
$2.7M
NICHD NIH HHS P30 HD018655NICHD NIH HHS P30 HD18655NIH HHS DP1 OD003347NINDS NIH HHS 1R01NS054044NINDS NIH HHS 2R37NS045737-05NINDS NIH HHS P01 NS038475NINDS NIH HHS P01 NS38475NINDS NIH HHS R01 NS031718NINDS NIH HHS R01 NS054044NINDS NIH HHS R01 NS31718NINDS NIH HHS R37 NS045737
6 · The paper itself

Abstract

Progress in the development of rat models of human periventricular white matter injury (WMI) has been hampered by uncertainty about the developmental window in different rodent strains that coincides with cerebral white matter development in human premature infants. To define strain-specific differences in rat cerebral white matter maturation, we analyzed oligodendrocyte (OL) lineage maturation between postnatal days (P)2 and P14 in three widely studied strains of rat: Sprague-Dawley, Long-Evans and Wistar (W). We previously reported that late OL progenitors (preOL) are the major vulnerable cell type in human periventricular WMI. Strain-specific differences in preOL maturation were found at P2, such that the W rat had the highest percentage and density of preOL relative to the other strains. Overall, at P2, the state of OL maturation was similar to preterm human cerebral white matter. However, by P5, all three strains displayed a similar magnitude and extent of OL maturation that persisted with progressive myelination between P7 and P14. PreOL were the predominant OL lineage stage present in the cerebral cortex through P14, and thus OL lineage maturation occurred latter than in white matter. The hippocampus also displayed a later onset of preOL maturation in all three strains, such that OL lineage maturation and early myelination was not observed to occur until about P14. This timing of preOL maturation in rat cortical gray matter coincided with a similar timing in human cerebral cortex, where preOL also predominated until at least 8 months after full-term birth. These studies support that strain-specific differences in OL lineage immaturity were present in the early perinatal period at about P2, and they define a narrow window of preterm equivalence with human that diminishes by P5. Later developmental onset of preOL maturation in both cerebral cortex and hippocampus coincides with an extended window of potential vulnerability of the OL lineage to hypoxia-ischemia in these gray matter regions.

Indexed as

Cell LineageAnimalsCerebral CortexHippocampusHumansOligodendrogliaRatsRats, Long-EvansRats, Sprague-DawleyRats, WistarSpecies SpecificityStem Cells

Identifiers

PMID21865655
PMCPMC3225247
OpenAlexW2033122192

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.